In addition to affecting NF-κB signaling, CYLD loss or low expression also sensitizes MM cells to Wnt ligands, indicating another possible tumor-suppressive mechanism of CYLD in MM [169]. This evidence concerns the gene NFKB1 and Miyoshi myopathy.